Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta‐analysis
Diabetic Medicine · 2025-12 · 42 (12)
DOI: 10.1111/dme.70157 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Diabetic Medicine, online erschienen am 07.10.2025. Verfasst von Hellena Hailu Habte-Asres und 4 weiteren Autor:innen. Beteiligte Einrichtung: Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK. Hauptthemen laut MEDLINE: Renal Dialysis, Diabetic Retinopathy, Diabetic Nephropathies, Kidney Failure, Chronic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
People with diabetes receiving haemodialysis are at increased risk of diabetic retinopathy (DR) and other ocular complications. Despite this heightened vulnerability, evidence on the prevalence of such conditions in this population is limited. This review aimed to synthesise the existing literature on the prevalence of DR and other ocular conditions, and to evaluate screening rates in people with diabetes undergoing haemodialysis.
Methods
A systematic search of MEDLINE, EMBASE and CINAHL databases was conducted to identify studies reporting on the prevalence of DR, diabetic maculopathy and other ocular conditions in people with diabetes on haemodialysis. Eight articles meeting inclusion criteria were included. Pooled prevalence estimates and 95% confidence intervals (CIs) were calculated using random‐effects models.
Results
The pooled prevalence of DR was 49.1% (95% CI: 23.1–75.4), while diabetic maculopathy prevalence was 32.5% (95% CI: 10.9–59.1). Other ocular complications reported included cataracts (53.4%), conjunctival calcification (63%) and corneal calcification (45.3%). Notably, 54.3% (95% CI: 35.4–72.6) of individuals on haemodialysis had not undergone eye screening in over two years.
Conclusion
This review reveals a high prevalence of DR and other ocular complications in people with diabetes undergoing haemodialysis, alongside significant under‐screening. Future research should focus on developing and accessing targeted interventions to improve screening uptake in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
- Royal Free London NHS Foundation Trust, London, UK.
- Colorado Technical University, Colorado Springs, Colorado, USA.
- UCL Department of Nephrology, University College London, Royal Free Campus, London, UK.
- Centre for Public Health, Queen's University Belfast, Belfast, UK.
ORCID-Profile: Angus Forbes, David C Wheeler, Tunde Peto
Zitieren
APA
Habte-Asres, H. H., Hailu, F., Forbes, A., Wheeler, D. C., & Peto, T. (2025). Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta‐analysis. Diabetic Medicine, 42(12). https://doi.org/10.1111/dme.70157
Vancouver
Habte-Asres HH, Hailu F, Forbes A, Wheeler DC, Peto T. Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta‐analysis. Diabetic Medicine. 2025;42(12). doi:10.1111/dme.70157
BibTeX
@article{HabteAsres2025,
author = {Habte-Asres, Hellena Hailu and Hailu, Frehiwot and Forbes, Angus and Wheeler, David C and Peto, Tunde},
title = {Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta‐analysis},
journal = {Diabetic Medicine},
year = {2025},
volume = {42},
number = {12},
doi = {10.1111/dme.70157}
}
EUVIMED